MEDIFAST INC
For the period ended Oct 30, 2024. Filed Nov 4, 2024.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Oct 30, 2024 · Filed Nov 4, 2024
Use the contents to explore the available documents and sections.
MED$12.81+0.6%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Outlook
Outlook
The company expects fourth quarter 2024 revenue to be in the range of $100 million to $120 million and fourth quarter 2024 diluted loss per share to be in the range of $0.10 to $0.65. The EPS range excludes any gains or losses from changes in the market price of the company’s LifeMD common stock investment.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.